From a Molecular Biological Viewpoint, Does Endothelin Type A Receptor Antagonist Therapy Reduce Diabetes-induced Testicular Damage in Rats?
Articles > Article · 2010
Authors: Buket KOSOVA, Vildan BOZOK, Altuğ YAVAŞOĞLU, Ahmet Barış ALTAY, Hüseyin AKTUĞ
Urology, Journal Indexed in SCI Expanded, International, WoS, 2010, vol 77, pp 250.e7-250.e13
DOI: 10.1016/j.urology.2010.04.052
Summary
OBJECTIVES To evaluate the therapeutic effects of a selective endothelin type A receptor antagonist (ERA-A) on testis of streptozotocin (STZ)-induced diabetic rats.